BIM 187 steride acetate InChi: InChI=1S/C17H19N3O3S/c1-10-8-18-15(11(2)16(10)23-4)9-24(21)17-19-13-6-5-12(22-3)7-14(13)20-17/h5-8H

InChi: InChI=1S/C17H19N3O3S/c1-10-8-18-15(11(2)16(10)23-4)9-24(21)17-19-13-6-5-12(22-3)7-14(13)20-17/h5-8H

17)25-10-3-1-9(2-4-10)7-23-11-5-19-6-12(20(21)22)18-13(19)24-8-11/h1-4

Acalabrutinib (ACP-196) inhibits tyrosine phosphorylation of downstream targets of ERK

EFdA-TP can block RT as a translocation-defective RT inhibitor that dramatically slows DNA synthesis

BIM 187 steride acetate InChi: InChI=1S/C17H19N3O3S/c1-10-8-18-15(11(2)16(10)23-4)9-24(21)17-19-13-6-5-12(22-3)7-14(13)20-17/h5-8HBombesin has common effects on the gastrointestinal tract and feeding behavior. Bombesin acts on two types of receptors including one with high affinity for neuromedin B and another with high affinity for bombesin and gastrin releasing peptide (GRP). BIM 187is a new peptide of bombesin while BIM 189 is a potent bombesin antagonis. In vitro: Bombesin stimulates mainly the bombesin high affinity receptor, and BIM 187 ([D Phe I ,Leu 8'9 ]litorin NHe), a